Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

Clinical trial NCT03800381 · COMPLETED

Trial details

NCT number: NCT03800381
Sponsor: University of Florida
Status: COMPLETED
Study type: OBSERVATIONAL

Tuberculosis Human Immunodeficiency Virus Coinfection

Start date: 2019-01-28
Primary completion: 2024-08-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.